CMS
60
2
PG
50
2
BXP
49
-3
CPB
22
-5
FFIV
66
-4
AVGO
18
-9
O
17
-13
GE
61
-3
AN
50
-5
FSLR
44
-2
URBN
48
-6
AA
56
15
SYF
86
-6
AXP
67
-2
DNB
74
-6
A
37
-2
STT
64
2
EQR
54
3
IRM
41
3
VRSK
68
-12
CMS
60
2
PG
50
2
BXP
49
-3
CPB
22
-5
FFIV
66
-4
AVGO
18
-9
O
17
-13
GE
61
-3
AN
50
-5
FSLR
44
-2
URBN
48
-6
AA
56
15
SYF
86
-6
AXP
67
-2
DNB
74
-6
A
37
-2
STT
64
2
EQR
54
3
IRM
41
3
VRSK
68
-12
Financhill
Back

Enlivex Therapeutics Vs. Can Fite Biofarma Industry Stock Comparison

Sell
17

ENLV
Enlivex Therapeutics

Last Price:
1.06
Seasonality Move:
14.56%
Sell
42

CANF
Can Fite Biofarma

Last Price:
1.95
Seasonality Move:
-4.74%
Sell
17
Enlivex Therapeutics (ENLV) is a Sell

Is Enlivex Therapeutics a Buy, Sell or Hold?

  • The current Enlivex Therapeutics [ENLV] share price is $1.07. The Score for ENLV is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • ENLV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $1.96. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENLV Stock Price Chart

What is Enlivex Therapeutics's stock price today?

  • The Enlivex Therapeutics share price today is $1.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENLV is experiencing slight buying pressure.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $1.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.

ENLV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 23.24 Sell
Chaikin Money Flow: 43470 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.21 - 1.53) Sell
Bollinger Bands (100): (1.25 - 1.51) Sell

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 33.81 Sell
Chaikin Money Flow: -36669 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.07 - 2.65) Sell
Bollinger Bands (100): (2.02 - 3.08) Sell

ENLV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.18 Sell
20-day SMA: 1.33 Sell
50-day SMA: 1.43 Sell
200-day SMA: 1.9 Sell
8-day EMA: 1.18 Sell
20-day EMA: 1.29 Sell
50-day EMA: 1.37 Sell
200-day EMA: 1.73 Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.07 Sell
20-day SMA: 2.28 Sell
50-day SMA: 2.25 Sell
200-day SMA: 2.4 Sell
8-day EMA: 2.07 Sell
20-day EMA: 2.19 Sell
50-day EMA: 2.29 Sell
200-day EMA: 2.48 Sell

Enlivex Therapeutics Earnings Growth & ENLV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.10 per share.

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.

Enlivex Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):